When co-cultured with AML cell lines U937 and THP1 and 8F4 bi-specific antibody for 18 h, healthy donor CD5+ T-cells displayed increased surface expression of the early T-cell activation marker CD69 in a dose dependent manner (Figures 4A,B and Supplementary Figure 2). The gene discussed is CD5; the disease is acute myeloid leukemia.